当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:252.99亿  总市值:326.16亿
流通股本:7.65亿   总股本:9.86亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金740,358,831.821,836,170,338.41,334,950,275.33840,718,464.86
收到的税费返还26,804,625.4210,546,104.0910,546,104.0910,546,104.09
收到其他与经营活动有关的现金36,256,368.2769,811,541.8551,386,223.2515,866,444.17
经营活动现金流入的平衡项目0000
经营活动现金流入小计803,419,825.511,916,527,984.341,396,882,602.67867,131,013.12
购买商品、接受劳务支付的现金469,391,325.131,732,587,358.041,319,202,006.33883,180,593.52
支付给职工以及为职工支付的现金292,997,853.31,216,708,662.84929,835,245.36666,064,219.15
支付的各项税费27,815,876.7589,149,699.7569,060,203.9443,733,104.27
支付其他与经营活动有关的现金37,545,966.83311,923,473.25192,257,231.65139,504,767.78
经营活动现金流出的平衡项目0000
经营活动现金流出小计827,751,022.013,350,369,193.882,510,354,687.281,732,482,684.72
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-24,331,196.5-1,433,841,209.54-1,113,472,084.61-865,351,671.6
二、投资活动产生的现金流量:
收回投资收到的现金481,065,293.221,901,811,816.6901,371,865.77250,000,000
取得投资收益收到的现金1,781,547.959,430,216.084,834,002.45389,043.54
处置固定资产、无形资产和其他长期资产收回的现金净额3801,865,0001,865,0001,865,000
收到的其他与投资活动有关的现金7,546,867.6944,160,556.1133,177,403.7824,983,805.7
投资活动现金流入的平衡项目0000
投资活动现金流入小计490,394,088.861,957,267,588.79941,248,272277,237,849.24
购建固定资产、无形资产和其他长期资产支付的现金161,199,762.48690,987,533.01620,759,009.17395,713,348.07
投资支付的现金649,000,0002,159,000,0001,404,000,012.5830,000,000
支付其他与投资活动有关的现金21,820,04162,189.34--
投资活动现金流出的平衡项目0000
投资活动现金流出小计832,019,803.482,850,049,722.352,024,759,021.671,225,713,348.07
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-341,625,714.62-892,782,133.56-1,083,510,749.67-948,475,498.83
三、筹资活动产生的现金流量:
吸收投资收到的现金-1,501,566.251,566.25-
其中:子公司吸收少数股东投资收到的现金-1,501,566.251,566.25-
取得借款收到的现金1,421,654,234.12,306,748,582.681,928,788,474.471,434,543,532.27
收到其他与筹资活动有关的现金676,829.086,350,285.824,641,807.393,725,476.58
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,422,331,063.182,314,600,434.751,933,431,848.111,438,269,008.85
偿还债务支付的现金997,243,377.51,174,018,295.57943,497,136.23634,028,085.17
分配股利、利润或偿付利息支付的现金23,008,576.1773,790,126.9352,050,486.6533,862,165.97
支付其他与筹资活动有关的现金15,301,114.2643,646,237.2737,854,02927,995,206.63
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,035,553,067.931,291,454,659.771,033,401,651.88695,885,457.77
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额386,777,995.251,023,145,774.98900,030,196.23742,383,551.08
四、汇率变动对现金及现金等价物的影响-791,648.4312,014,641.06-6,855,136.194,770,876.49
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额20,029,435.7-1,291,462,927.06-1,303,807,774.24-1,066,672,742.86
加:期初现金及现金等价物余额2,486,679,108.823,778,142,035.883,778,142,035.883,778,142,035.88
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,506,708,544.522,486,679,108.822,474,334,261.642,711,469,293.02
补充资料:
净利润--1,380,108,858.26--687,709,041.49
资产减值准备-88,178,776.72-381,606.68
固定资产和投资性房地产折旧-244,829,609.17-123,119,142.4
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-244,829,609.17-123,119,142.4
无形资产摊销-31,734,565.71-15,755,581.48
长期待摊费用摊销-11,504,314.2-6,539,949.71
处置固定资产、无形资产和其他长期资产的损失--12,777,848.8--12,938,477.3
固定资产报废损失-938,428.84-618,756.85
公允价值变动损失-47,678,755.74-32,147,749.55
财务费用-6,033,960.32-3,341,025.46
投资损失-23,553,900.59-27,835,848.07
递延所得税-16,350,840.82-1,167,974.88
其中:递延所得税资产减少-16,350,840.82-1,167,974.88
存货的减少--159,273,263.21--24,938,026.09
经营性应收项目的减少-54,205,110-73,730,473.55
经营性应付项目的增加--415,293,504.21--438,357,576.19
其他--10,673,190.91-4,588,255.92
现金的期末余额-2,486,679,108.82-2,711,469,293.02
减:现金的期初余额-3,778,142,035.88-3,778,142,035.88
公告日期2025-04-262025-03-282024-10-302024-08-31
审计意见(境内)标准无保留意见
TOP↑